BlackRock
NVO

BlackRock’s Novo Nordisk NVO Stock Holding History

BlackRock’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-560,000
Closed -$79.9M – 5291
2024
Q2 		$79.9M Sell
560,000
-560,000
-50% -$74.2M ﹤0.01% 2159
2024
Q1 		$144M Buy
+1,120,000
New +$133M ﹤0.01% 1848

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

BlackRock's NVO Position: Q1 2026 in Review

BlackRock reduced its Novo Nordisk (NVO) stake by 8.8% in Q1 2026, selling an estimated $13.4M and leaving 2,951,353 shares worth $108M. The position accounts for ﹤0.01% of the portfolio, ranked #2056.

BlackRock first reported a position in NVO in Q2 2016 and has held it in 40 quarters since. The position peaked at $780M in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • BlackRock held 2,951,353 shares of Novo Nordisk worth $108M as of Q1 2026.
  • BlackRock sold 283,549 Novo Nordisk shares in Q1 2026, an estimated $13.4M.
  • Novo Nordisk made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #2056 holding.
  • BlackRock first reported a position in Novo Nordisk in Q2 2016 and has held it in 40 quarters since.
  • BlackRock's Novo Nordisk position peaked at $780M in Q2 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.